UnknownEarly Phase 1NCT01524016

68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia

Studying Oncogenic osteomalacia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Peking Union Medical College Hospital
Principal Investigator: Fang Li, MD
Department of Nuclear Medicine, Peking Union Medical College Hospital
Intervention: 68Ga-DOTATATE(drug)
Enrollment: 100 target
Eligibility: 18-70 years · All sexes
Timeline: 2011 – 2017

Study locations (1)

Department of Nuclear Medicine, Peking Union Medical College Hopital, Beijing, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01524016 on ClinicalTrials.gov

Other trials for Oncogenic osteomalacia

Additional recruiting or active studies for the same condition.

See all trials for Oncogenic osteomalacia →

← Back to all trials